ChiCTR‐TRC‐10000922.

Study name	Autologous transplantation of cord blood derived stem cells for neonatal hypoxic‐ischaemic encephalopathy
Methods	Randomised parallel controlled trial
Participants	Inclusion criteria: infants with HIE, less than 24 hours after birth, pH of cord blood < 7.0, Apgar score < 7;  Exclusion criteria: maternal sepsis; chromosome abnormality or contagious disease;  severe congenital anomaly; failure of cord blood collection or transplantation
Interventions	Autologous transplantation of cord blood versus standard care
Outcomes	Primary outcomes: electroencephalogram; intellectual development; behavior development; neuron specific enolase; diffusion‐weighted imaging Secondary outcomes: clinical presentations; blood routine, urine routine, liver function and kidney function
Starting date	Date of registration: 27 June 2010.
Contact information	Xiao‐zhuang Zhang, zxz3861@163.com, Guangzhou, China
Notes	Study sponsor: Guagndong Maternal and Children's Hospital